← Open Payments lookup

MADINA DIXON: Open Payments

NPI 1912268350 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$744 in 22 payments from 10 companies in 2025. Trend: 2023 $605 · 2024 $208 · 2025 $744

Food & beverage: $744
CompanyPaymentsAmount
Astellas Pharma US Inc7$263
Sumitomo Pharma America, Inc.4$184
Axsome Therapeutics, Inc.1$124
MAYNE PHARMA COMMERCIAL LLC3$49
Currax Pharmaceuticals LLC2$31
Abbott Laboratories1$24
Lilly USA, LLC1$19
Novo Nordisk Inc1$18
Evofem Biosciences, Inc.1$17
Acella Pharmaceuticals, LLC1$14

Products named: Veozah, GEMTESA, Auvelity, ONZETRA XSAIL, PROCLAIM, MOUNJARO, Saxenda, Phexxi.

Industry payments across MS — which companies pay providers there.